Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine.

Cell cultures and tissues often contain cellular subpopulations that potentially interfere with or contaminate other cells of interest. However, it is difficult to eliminate unwanted cells without damaging the very cell population one is seeking to protect, especially established tissue. Here, we report a method of eliminating a specific subpopulation of cells from a mixed 2D or 3D cell culture in vitro and a mixed-population in vivo tumor model by using antibody-photosensitizer conjugates (APC) with a near infrared (NIR) phthalocyanine-derivative (IRdye700DX, IR700) combined with NIR light exposure with minimal damage to non-targeted cells. Thus, APC combined with NIR light exposure holds promise as a method of removing specific cells from mixed cell cultures and tumors.

[1]  P. Choyke,et al.  Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model , 2014, PloS one.

[2]  P. Choyke,et al.  Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor , 2014, Molecular oncology.

[3]  H. Kohrt,et al.  Intratumoral Immunization: A New Paradigm for Cancer Therapy , 2014, Clinical Cancer Research.

[4]  J. O’Shea,et al.  In Search of Magic Bullets: The Golden Age of Immunotherapeutics , 2014, Cell.

[5]  S. Yamanaka,et al.  Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.

[6]  G. Burmester,et al.  Emerging cell and cytokine targets in rheumatoid arthritis , 2014, Nature Reviews Rheumatology.

[7]  Junichi Kiryu,et al.  Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application , 2014, Stem cell reports.

[8]  T. Okazaki,et al.  A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application , 2013, Nature Immunology.

[9]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[10]  H. Onoe,et al.  Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate , 2013, Stem cell reports.

[11]  G. Dranoff,et al.  Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies , 2013, The Journal of experimental medicine.

[12]  S. Moon,et al.  Inhibition of pluripotent stem cell-derived teratoma formation by small molecules , 2013, Proceedings of the National Academy of Sciences.

[13]  Maria Sundberg,et al.  Improved Cell Therapy Protocols for Parkinson's Disease Based on Differentiation Efficiency and Safety of hESC‐, hiPSC‐, and Non‐Human Primate iPSC‐Derived Dopaminergic Neurons , 2013, Stem cells.

[14]  N. Benvenisty,et al.  Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells , 2013, Nature Communications.

[15]  Michael R. Green,et al.  Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. , 2013, The Journal of clinical investigation.

[16]  P. Choyke,et al.  Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors. , 2013, ACS nano.

[17]  B. Prakken,et al.  T cells out of control—impaired immune regulation in the inflamed joint , 2013, Nature Reviews Rheumatology.

[18]  H. Johnsen,et al.  Cancer stem cell definitions and terminology: the devil is in the details , 2012, Nature Reviews Cancer.

[19]  S. Yamanaka.  Induced pluripotent stem cells: past, present, and future. , 2012, Cell stem cell.

[20]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[21]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[22]  Hisataka Kobayashi,et al.  Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. , 2012, Bioconjugate chemistry.

[23]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[24]  George Coukos,et al.  Cancer immunotherapy comes of age , 2011, Nature.

[25]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[26]  K. Kaibuchi,et al.  Numb controls E-cadherin endocytosis through p120 catenin with aPKC , 2011, Molecular biology of the cell.

[27]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[28]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[29]  N. Benvenisty,et al.  The tumorigenicity of human embryonic and induced pluripotent stem cells , 2011, Nature Reviews Cancer.

[30]  Krishanu Saha,et al.  Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.

[31]  Kevin Eggan,et al.  Progress toward the clinical application of patient-specific pluripotent stem cells. , 2010, The Journal of clinical investigation.

[32]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[33]  N. Rosenthal,et al.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications , 2008, Nature Reviews Drug Discovery.

[34]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[35]  M L Yarmush,et al.  Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.